Sain Biotechnology Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Corporate

  • Financing Rounds
  • 3

Sain Biotechnology General Information

Description

Developer of tumor cell therapies intended to provide innovative immunotherapy treatments for cancer patients. The company utilizes proprietary technology platforms for the development of chimeric antigen receptor T-cell, natural killer cell, and T-cell receptor therapies, enabling healthcare providers to access advanced clinical-stage treatments for hematologic malignancies and solid tumors.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Room 2, Building D3, Block B9, Phase I, High-tech Medical Device Park
  • Wuhan National Bio-industry Base, East Lake High-tech Development Zone
  • Wuhan, Hubei 430206
  • China
+86 134
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Room 2, Building D3, Block B9, Phase I, High-tech Medical Device Park
  • Wuhan National Bio-industry Base, East Lake High-tech Development Zone
  • Wuhan, Hubei 430206
  • China
+86 134

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sain Biotechnology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sain Biotechnology‘s full profile, request access.

Request a free trial

Sain Biotechnology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sain Biotechnology Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sain Biotechnology‘s full profile, request access.

Request a free trial

Sain Biotechnology FAQs

  • When was Sain Biotechnology founded?

    Sain Biotechnology was founded in 2015.

  • Where is Sain Biotechnology headquartered?

    Sain Biotechnology is headquartered in Wuhan, China.

  • What is the size of Sain Biotechnology?

    Sain Biotechnology has 18 total employees.

  • What industry is Sain Biotechnology in?

    Sain Biotechnology’s primary industry is Drug Discovery.

  • Is Sain Biotechnology a private or public company?

    Sain Biotechnology is a Private company.

  • What is Sain Biotechnology’s current revenue?

    The current revenue for Sain Biotechnology is .

  • Who are Sain Biotechnology’s investors?

    Optics Valley Financial Holdings Group, Wuhan Optics Valley Industrial Investment, and 3Sbio have invested in Sain Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process